The Targeted Radiopharmaceuticals (TRP) Summit: an industry-led platform that discusses challenges and opportunities faced by developers of theranostic radio ligand therapies. Topics such as the identification and validation of new targets and ways to improve the current clinical design methodologies will be discussed by speakers and panels.
For the 2021 edition of this conference, it is possible to attend either in-person in Berlin or remotely via a dedicated digital networking platform with all the access to the conference content.
On the 9th of December Jan van Bodegom, CEO of Coretag, gave a presentation on behalf of FIELD-LAB about the future of effective cancer therapy using alpha emitting isotopes. He discussed how to avoid delayed damage, the ideal half-life for effectiveness with minimal side effects and how to secure a reliable supply chain of essential medical isotopes. He also addressed the role of FIELD-LAB in advancing the discovery and development of promising new radiopharmaceuticals.
“Accelerated availability of targeted alpha therapy for patients can make a real difference”
When: Tuesday 7 until Thursday 9, December 2021
Where: Berlin and online
If you wish to learn more about the speakers, the programme or registration, please check the TRP Summit website.
If you want to get in touch about the TRP Summit or want to learn more about FIELD-LAB and Advancing Nuclear Medicine, please leave your contact information in this form. We will reach out to you as soon as possible.